CompletedNCT05179785
Official study titleEstablishing the Effect of Electroencephalography (EEG)-Guided Theta Burst Stimulation on Reducing Mania/Hypomania-related Affect and Reward Driven Behavior in Bipolar Disorder
This study has finished and is no longer accepting participants.
In PittsburghBipolarityDevice studyAges 18–35
- Countries
- United States
- Sponsor
- Mary Phillips, MD MD (Cantab)
CompletedNCT00194129
Official study titleA Randomized, Double Blind Comparison of Lithium Monotherapy Versus Lithium Plus Divalproex for the Outpatient Management of Hypomania/Mania in Patients With Rapid Cycling Bipolar Disorder Comorbid With Substance Abuse/Dependence
This study has finished and is no longer accepting participants.
In ClevelandBipolarityMedication studyAges 16–65
- Countries
- United States
- Sponsor
- University Hospitals Cleveland Medical Center
CompletedNCT03257865
What is this study about?Researchers compared Brexpiprazole and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockBipolarityMedication studyAges 18–65
- Countries
- United States, Croatia, Ukraine
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Not Yet RecruitingNCT07208721
Official study titleThe Key to Emotional Balance: The Effect of a Positive Psychotherapy-Based Balance Model on Emotion Regulation, Recovery, and Life Purpose in Bipolar Disorder
This study isn't recruiting yet.
Location not clearly listedBipolarityBehavioural studyAges 18–65
- Countries
- Sponsor
- TC Erciyes University
CompletedNCT05340504
Official study titleExperimentally Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder
This study has finished and is no longer accepting participants.
In CharlestonBipolarityMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Medical University of South Carolina
Active Not RecruitingNCT04815239
Official study titleEarly Intervention for Youth at High Risk for Bipolar Disorder
This study is no longer accepting new participants.
In PittsburghBipolarityBehavioural studyAges 12–18
- Countries
- United States
- Sponsor
- University of Pittsburgh
Active Not RecruitingNCT03245593
Official study titleShared Medical Decision Making in the Prophylactic Treatment of Bipolar Disorder
This study is no longer accepting new participants.
Multiple locations, including BéziersBipolarityInterventional studyAges 18+
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
WithdrawnNCT04211428
Official study titleA Non-Interventional Pilot Study to Explore the Role of Gut Flora in Bipolar Disorder
This study was withdrawn before enrollment.
In VenturaBipolarityObservational study
- Countries
- United States
- Sponsor
- ProgenaBiome
CompletedNCT00238485
What is this study about?This study evaluated the safety of Licarbazepine for people with bipolarity.
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18–70
- Countries
- Sponsor
- Novartis
CompletedNCT00228059
What is this study about?This study evaluated the safety of Licarbazepine for people with bipolarity.
This study has finished and is no longer accepting participants.
In CerritosBipolarityMedication studyAges 18–70
- Countries
- United States
- Sponsor
- Novartis
CompletedNCT04819776
What is this study about?Researchers compared Iloperidone and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockBipolarityMedication studyAges 18–65
- Countries
- United States, Bulgaria, Poland
- Sponsor
- Vanda Pharmaceuticals
CompletedNCT00139594
What is this study about?Researchers studied licarbazepine, tracking side effects to assess safety and tolerability in people with bipolarity type I during a manic episode.
This study has finished and is no longer accepting participants.
Multiple locations, including La PalmaBipolarityMedication studyAges 18–70
- Countries
- United States, Canada, Austria, + 10 others
- Sponsor
- Novartis